Fund Details
UTI Dual Advantage Fixed Term Fund Series II III (1998 Days) Regular Growth
| Risk | Moderate |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.10% |
| NAV | ₹15.02 (08 Apr 2021) |
|---|---|
| Fund Started | 19 Oct 2015 |
| Fund Size | ₹31 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Haryana State | Others | SDL | 19.1% |
| Infosys Ltd. | Technology | Equity | 3.1% |
| HDFC Bank Ltd. | Financial | Equity | 2.9% |
| ICICI Bank Ltd. | Financial | Equity | 2.2% |
| Eris Lifesciences Ltd | Healthcare | Equity | 0.9% |
| Gujarat State Petronet Ltd. | Energy | Equity | 0.8% |
| Mahindra & Mahindra Ltd. | Automobile | Equity | 0.8% |
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 0.8% |
| Aditya Birla Capital Ltd. | Financial | Equity | 0.5% |
| GHCL Ltd. | Chemicals | Equity | 0.3% |
Fund Managers
UTI Dual Advantage Fixed Term Fund Series II III (1998 Days) Regular Growth Details
UTI Dual Advantage Fixed Term Fund Series II III (1998 Days) Regular Growth is a Hybrid Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 19 Oct 2015. null is the Current Fund Manager of UTI Dual Advantage Fixed Term Fund Series II III (1998 Days) Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹31 Cr and the Latest NAV as of 08 Apr 2021 is ₹15.02.
The UTI Dual Advantage Fixed Term Fund Series II III (1998 Days) Regular Growth is rated Moderate risk.
Investment Objective
The scheme seeks to generate income and reduce interest rate volatility by investing in fixed income securities that are maturing on or before the date of maturity of the Scheme and generate capital appreciation by investing in equity and equity related instruments.
